The global enteral feeding devices market size was USD 4.50 billion in 2023, estimated at USD 4.73 billion in 2024 and is anticipated to reach around USD 7.67 billion by 2034, expanding at a CAGR of 4.95% from 2024 to 2034.
The global enteral feeding devices market size accounted for USD 4.73 billion in 2024 and is predicted to reach around USD 7.67 billion by 2034, growing at a CAGR of 4.95% from 2024 to 2034.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
Enteral feeding devices are medical devices used to deliver liquid nutrition directly to the stomach or intestines of those people who are unable to consume food orally due to some medical conditions or swallowing difficulties. Enteral feeding devices include feeding pumps, flexible tubes, and syringes. These devices help to administer liquid nutrition, medications, and supplements. These devices are placed through the nose or mouth or surgically implanted into the stomach. The global enteral feeding devices market has registered a significant growth over the years. There has been a significant increase in the demand for enteral feeding devices during the COVID-19 pandemic due to a large number of people requiring nutritional support, particularly those affected by COVID-19.
The U.S. enteral feeding devices market size was valued at USD 1.20 billion in 2023 and is expected to be worth USD 2.06 billion by 2034, growing at a CAGR of 5.03% between 2024 and 2034.
North America held the largest share of the market in 2023 due to the increasing health awareness, rising geriatric population, and rising healthcare expenditure, which supports the adoption of advanced medical devices such as enteral feeding devices. Moreover, a significant growth in premature births in the U.S. contributed to the market growth. As premature birth increases, the demand for pediatric enteral feeding devices increases, which is vital in delivering essential nutrition to premature babies.
As per the Population Reference Bureau, the number of Americans ages 65 or above is anticipated to increase from 58 million in 2022 to 82 million by 2050, a 47% increase.
According to the National Center for Health Statistics (NCHS), the rate of premature birth in the U.S. grew 12% from 2014 to 2022.
The market in Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period due to the high prevalence of chronic diseases, such as diabetes, cancer, and chronic kidney disease (CKD). These diseases often require enteral feeding devices for dietary management. Furthermore, the growing geriatric population in countries such as India and Japan is projected to boost market growth.
The market is expected to grow rapidly in the coming years due to the increasing advancements in medical devices and the growing elderly population. Conditions such as dysphagia, dementia, and gastrointestinal disorders are common among elderly people. These conditions may sometimes lead to swallowing difficulties. As people age, they require nutritional support. Thus, the growing elderly population significantly fuels the market. For instance,
According to the World Health Organization (WHO), the number of people aged 60 years or older is projected to increase from 1 billion in 2020 to 2.1 billion by 2050. The number of people aged 80 years or older is projected to triple between 2020 and 2050 to reach 426 million.
Report Highlights | Details |
Market Size by 2034 | USD 75.45 Billion |
Market Size in 2023 | USD 28.86 Billion |
Market Size in 2024 | USD 31.49 Billion |
Market Growth Rate from 2024 to 2034 | CAGR of 9.13% |
Base Year | 2023 |
Forecast Period | 2024 to 2034 |
Segments Covered | Age Group, Product, Application, End User, and Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Prevalence of Chronic Diseases and Rising Number of Surgeries
The growing prevalence of chronic diseases across the globe is expected to drive the market during the forecast period. Chronic diseases such as diabetes, cancer, chronic kidney disease (CKD), and Alzheimer’s disease often cause serious problems, such as swallowing difficulty. However, proper nutrition is important in many chronic diseases, preventing complications and improving health outcomes. Thus, as the number of patients with these conditions increases, so does the need for nutritional support, which significantly boosts the market.
As per the National Library of Medicine, about one in three adults worldwide suffer from multiple chronic conditions (MCCs).
Furthermore, the rising number of surgical procedures is expected to drive the market. Surgical procedures often cause difficulties with oral intake after surgery due to pain or reduced appetite. However, enteral feeding devices play a vital role in delivering essential nutrition to patients recovering from surgical interventions, promoting faster recovery.
According to the National Institute of Health (NIH), around 310 million major surgeries are performed worldwide every year.
Lack of awareness
The lack of awareness about the benefits and usage of enteral feeding devices among patients in underdeveloped regions hamper the market. If patients are unaware of the benefits of these devices in managing chronic conditions, their use becomes limited. Moreover, the lack of reimbursement policies for these devices deters some patients from adopting them.
Technological Advancements
The rising technological advancements in medical devices create lucrative opportunities in the market. Advancements in enteral feeding devices lead to user-friendly and portable devices, making them suitable for home care. Implementing real-time monitoring with these devices helps provide doctors with useful data about patient nutrition and feeding. Furthermore, the rising trend of self-medication and self-care propels the demand for these advanced devices.
The enteral feeding pump segment held a large share of the market in 2023. The segment growth is mainly attributed to the rising concern about overfeeding. Enteral feeding pumps offer accurate control over nutrition given to patients, guaranteeing precise delivery of nutrients or medications. This precision helps to prevent overfeeding, which may lead to complications. However, this accuracy is crucial in cancer treatment, as inaccurate nutrition levels may lead to complications that impede treatment effectiveness. These pumps offer flexibility to combine methods such as continuous feeding overnight and bolus feeding during the day to make the feeding process more tailored to the patient’s condition.
The enteral feeding tube segment is projected to grow rapidly during the forecast period. Enteral feeding tubes are available in a range of sizes. They are either inserted through the mouth or through the nose into the stomach. These tubes can be customized according to the patient’s needs and can also be used to remove stomach contents.
The adults segment held a major share of the market in 2023 due to the growing prevalence of age-related diseases, such as diabetes, dementia, chronic obstructive pulmonary disease, and gastrointestinal disorders. Moreover, the increasing instances of dysphagia in adults contributed to the segmental growth. Enteral feeding devices are required to supply nutritional supplements to people suffering from these ailments. For instance,
According to the National Institute of Health (NIH), dysphagia is common in adults. About 1 in 6 adults experience difficulty in swallowing.
The pediatrics segment is expected to register a significant growth rate in the coming. There has been a significant growth in the occurrence of malnutrition among children. This, in turn, boosts the demand for enteral feeding devices that are designed for infants, such as nasojejunal tubes, G-tubes, and jejunostomy tubes. As per the World Health Organization (WHO), around half of deaths among children under 5 years of age are linked to undernutrition. Moreover, the increasing instances of premature birth are expected to boost the segment. For instance,
According to the National Library of Medicine, over 400,000 babies are born prematurely every year in the U.S.
The cancer segment dominated the market in 2023. The segment is anticipated to expand at the fastest CAGR during the forecast period due to the rising cancer cases worldwide. Cancer treatment, such as chemotherapy and radiation therapy, often creates mouth sores or swallowing difficulties. This boosts the need for reliable solutions for delivering medications and nutrients to patients with such conditions, thereby driving the demand for enteral feeding devices. For instance,
As per the World Health Organization (WHO), nearly 20 million new cancer cases and 9.7 million cancer deaths were recorded worldwide in 2022. About 1 in 5 people develop cancer in their lifetime, and about 1 in 12 women and 1 in 9 men die from cancer.
The hospitals segment held a major share of the market in the enteral feeding devices market in 2023 due to the rising number of patients in hospitals requiring nutrition support. Moreover, factors such as easy accessibility to advanced medical devices, availability of skilled healthcare professionals, and the rising number of ICU admissions contributed to the market growth
Leading competitors contending in the global enteral feeding devices market are as follows:
Major Market Segments Covered:
By Product Type
By Age Group
By Application
By End User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Enteral Feeding Devices Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Enteral Feeding Devices Market
5.1. Covid-19: Enteral Feeding Devices Industry Impact
5.2. Enteral Feeding Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Enteral Feeding Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Enteral Feeding Devices Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Enteral Feeding Devices Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Integration of safety and programming features within the feeding devices
6.1.1.2. Development of portable feeding devices
6.1.2. Market Restraints
6.1.2.1. Complications associated with enteral feeding devices
6.1.3. Market Opportunities
6.1.3.1. Rapidly increasing awareness regarding enteral feeding
6.1.3.2. Increased focus on the improvement of healthcare infrastructure
Chapter 7. Global Enteral Feeding Devices Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Enteral Feeding Devices Market Revenue by Market Players
7.1.1.2. Enteral Feeding Devices Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Enteral Feeding Devices Market, By Product Type
8.1. Enteral Feeding Devices Market, by Product Type, 2024-2034
8.1.1. Administration Sets
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Enteral Feeding Pump
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Enteral Syringe
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Enteral Feeding Tube
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Enteral Feeding Devices Market, By Application
9.1. Enteral Feeding Devices Market, by Application, 2024-2034
9.1.1. Gastrointestinal Disease
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Malnutrition
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Neurological Disorder
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Enteral Feeding Devices Market, By Age Group
10.1. Enteral Feeding Devices Market, by Age Group, 2021-2034
10.1.1. Pediatrics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Adult
10.1.2.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Enteral Feeding Devices Market, By End-User
11.1. Enteral Feeding Devices Market, by End User, 2024-2034
11.1.1. Gastrointestinal Disease
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Cancer
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Malnutrition
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Neurological Disorder
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Enteral Feeding Devices Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue Forecast by Product Type(2021-2034)
12.1.2. Market Revenue Forecast by Application (2021-2034)
12.1.3. Market Revenue Forecast by Age Group (2021-2034)
12.1.4. Market Revenue Forecast by End User (2021-2034)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2034)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2034)
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type (2021-2034)
12.2.2. Market Revenue Forecast by Application (2021-2034)
12.2.3. Market Revenue Forecast by Age Group (2021-2034)
12.2.4. Market Revenue Forecast by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2034)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2034)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type (2021-2034)
12.3.2. Market Revenue Forecast by Application (2021-2034)
12.3.3. Market Revenue Forecast by Age Group (2021-2034)
12.3.4. Market Revenue Forecast by End User (2021-2034)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2034)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2034)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type (2021-2034)
12.4.2. Market Revenue Forecast by Application (2021-2034)
12.4.3. Market Revenue Forecast by Age Group (2021-2034)
12.4.4. Market Revenue Forecast by End User (2021-2034)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2034)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2034)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type (2021-2034)
12.5.2. Market Revenue Forecast by Application (2021-2034)
12.5.3. Market Revenue Forecast by Age Group (2021-2034)
12.5.4. Market Revenue Forecast by End User (2021-2034)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2034)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2034)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2034)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2034)
Chapter 13. Company Profiles
13.1. Cook Medical
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Abott Laboratories
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Fresenius Kabi
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Halyard Health
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Medtronic
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. Moog, Inc
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Nestle Health Science
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. VYGON
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Danone
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Cardinal Health
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
13.11. B.Braun
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin
13.11.4. Recent Developments and Strategies
13.12. Boston Scientific
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin
13.12.4. Recent Developments and Strategies
13.13. C.R. Bard
13.13.1. Company Overview, Business Information, Regional Presence
13.13.2. Product Portfolio Analysis
13.13.2.1. Product Details, Specification, Application
13.13.3. Revenue, Price, and Gross Margin
13.13.4. Recent Developments and Strategies
13.14. Conmed Corporation
13.14.1. Company Overview, Business Information, Regional Presence
13.14.2. Product Portfolio Analysis
13.14.2.1. Product Details, Specification, Application
13.14.3. Revenue, Price, and Gross Margin
13.14.4. Recent Developments and Strategies
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client